• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症疼痛的药物治疗

Pharmacological treatment of pain in multiple sclerosis.

作者信息

Solaro Claudio, Tanganelli Paolo, Messmer Uccelli Michele

机构信息

ASL 3 Hospitals, Department of Neurology, Via Oliva 22, Genoa 16153, Italy.

出版信息

Expert Rev Neurother. 2007 Sep;7(9):1165-74. doi: 10.1586/14737175.7.9.1165.

DOI:10.1586/14737175.7.9.1165
PMID:17868015
Abstract

Pain is a common symptom in multiple sclerosis (MS) and was recently estimated to be experienced by up to 75% of patients. Nociceptive and neuropathic pain in MS may be present concurrently and at different stages of the disease and may be associated with other symptoms. Evidence for treating pain in MS is limited. Many clinical features of pain are often unrecognized by clinicians and are difficult for patients to describe. Treatment is often based on anecdotal reports and clinical experience. We present a review of treatment options for pain in MS that should serve to update current knowledge, highlight shortcomings in clinical research and provide indications towards achieving evidence-based treatment of pain in MS.

摘要

疼痛是多发性硬化症(MS)的常见症状,最近估计高达75%的患者会经历疼痛。MS中的伤害性疼痛和神经性疼痛可能同时存在于疾病的不同阶段,并且可能与其他症状相关。治疗MS疼痛的证据有限。疼痛的许多临床特征往往未被临床医生识别,患者也难以描述。治疗通常基于轶事报道和临床经验。我们对MS疼痛的治疗选择进行了综述,旨在更新当前知识,突出临床研究中的不足,并为实现MS疼痛的循证治疗提供指导。

相似文献

1
Pharmacological treatment of pain in multiple sclerosis.多发性硬化症疼痛的药物治疗
Expert Rev Neurother. 2007 Sep;7(9):1165-74. doi: 10.1586/14737175.7.9.1165.
2
Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances.使用大麻素对多发性硬化症进行对症治疗:最新进展
Expert Rev Neurother. 2007 Sep;7(9):1157-63. doi: 10.1586/14737175.7.9.1157.
3
Pharmacological management of pain in patients with multiple sclerosis.多发性硬化症患者疼痛的药物治疗管理。
Drugs. 2010 Jul 9;70(10):1245-54. doi: 10.2165/11537930-000000000-00000.
4
Toward the development of rational therapies in multiple sclerosis: what is on the horizon?迈向多发性硬化症合理治疗方法的发展:未来有什么新进展?
Ann Neurol. 2007 Oct;62(4):314-26. doi: 10.1002/ana.21289.
5
The curtain is drawn for both natalizumab and fingolimod (FTY720): a new era of multiple sclerosis therapy has arrived.那他珠单抗和芬戈莫德(FTY720)都已落幕:多发性硬化症治疗的新时代已然来临。
Expert Rev Neurother. 2006 Nov;6(11):1587-90. doi: 10.1586/14737175.6.11.1587.
6
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
7
[Cannabinoids in multiple sclerosis -- therapeutically reasonable?].[大麻素用于多发性硬化症——在治疗上合理吗?]
Fortschr Neurol Psychiatr. 2005 Aug;73(8):463-9. doi: 10.1055/s-2004-830119.
8
Current therapeutic options of chronic leg ulcers.慢性腿部溃疡的当前治疗选择。
J Dtsch Dermatol Ges. 2008 May;6(5):389-401. doi: 10.1111/j.1610-0387.2008.06674.x.
9
Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.口腔黏膜δ9-四氢大麻酚/大麻二酚治疗多发性硬化相关神经病理性疼痛:一项非对照、开放标签的2年延长期试验。
Clin Ther. 2007 Sep;29(9):2068-79. doi: 10.1016/j.clinthera.2007.09.013.
10
[Pain in multiple sclerosis].
Rev Neurol (Paris). 2001 Sep;157(8-9 Pt 2):1072-8.

引用本文的文献

1
Individual Cerebral Blood Flow Responses to Transcranial Direct Current Stimulation at Various Intensities.不同强度经颅直流电刺激下的个体脑血流反应。
Brain Sci. 2020 Nov 13;10(11):855. doi: 10.3390/brainsci10110855.
2
Tolerability and Blinding of Transcranial Direct Current Stimulation in People with Parkinson's Disease: A Critical Review.帕金森病患者经颅直流电刺激的耐受性与盲法:一项批判性综述
Brain Sci. 2020 Jul 20;10(7):467. doi: 10.3390/brainsci10070467.
3
No Immediate Effects of Transcranial Direct Current Stimulation at Various Intensities on Cerebral Blood Flow in People with Multiple Sclerosis.
不同强度经颅直流电刺激对多发性硬化症患者脑血流无即时影响。
Brain Sci. 2020 Feb 4;10(2):82. doi: 10.3390/brainsci10020082.
4
Cannabis for Neuropathic Pain in Multiple Sclerosis-High Expectations, Poor Data.大麻用于治疗多发性硬化症的神经性疼痛——期望很高,数据不足。
Front Pharmacol. 2019 Oct 22;10:1239. doi: 10.3389/fphar.2019.01239. eCollection 2019.
5
Painful and involuntary multiple sclerosis.多发性硬化症伴疼痛和不由自主。
Expert Opin Pharmacother. 2011 Apr;12(5):763-77. doi: 10.1517/14656566.2011.540239. Epub 2011 Feb 17.
6
Multiple sclerosis-related central pain disorders.多发性硬化相关的中枢性疼痛障碍。
Curr Pain Headache Rep. 2010 Jun;14(3):189-95. doi: 10.1007/s11916-010-0108-8.
7
The symptomatic management of multiple sclerosis.多发性硬化症的症状管理。
Ann Indian Acad Neurol. 2009 Oct;12(4):291-5. doi: 10.4103/0972-2327.58278.